FBC Advises Rainbow Medical and Glusense in a $3M investment by Ping An Ventures

September, 2014 - Israel

Fischer Behar Chen Well Orion & Co. represented Glusense Ltd., a subsidiary of Rainbow Medical Ltd., in a fund raising round totaling USD 3 million from venture capital fund of the Chinese Insurance Corporation Ping An Insurance. Glusense develops an accurate, long-term, minimally invasive, implantable, continuous glucose sensor for diabetes patients. Ping An was ranked No.83 in Forbes’ Global 2000 league table in 2013, No.181 in U.S. Fortune Magazine’s Global 500 Leading Companies ranking, and No.1 among China’s non-State owned enterprises. Ping An was ranked No.84 in WPP Millward Brown’s BrandZ Top 100 Most Valuable Global Brands, and 6th on the “2013 Best Chinese Brand” ranking by Interbrand, the largest brand consultancy in the world, making it the top insurance brand in China. The key FBC professionals who were involved in the transaction were Raz Tepper (partner) and Naama Gil (associate).

dots